Dexrazoxane Size:Solid 10 mg resulting in increased recovery of

resulting in increased recovery of transplantable HSCs

GW-7647 (100 nM) causes a 24% reduction in AQP9 protein abundance in HepG2 cells

nAChR agonist 1

2019 Feb 17

Dexrazoxane Size:Solid 10 mg resulting in increased recovery ofDexrazoxane is a bisdioxopiperazine with iron chelating, chemoprotective, cardioprotective, and antineoplastic activities. After hydrolysis to an active form that is similar to ethylenediaminetetraacetic acid (EDTA), dexrazoxane chelates iron, limiting the formation of free radical generating anthracycline iron complexes, which may minimize anthracycline iron complex mediated oxidative damage to cardiac and soft tissues. This agent also inhibits the